We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Insurer Uses Clout to Negotiate Drug Prices; Critics Challenge Medicare Brandname Pricing
Insurer Uses Clout to Negotiate Drug Prices; Critics Challenge Medicare Brandname Pricing
UnitedHealth Group plans to use its market strength to negotiate prices to help consumers purchase expensive specialty drugs, adding to a growing press from doctors, patient advocates and lawmakers to rein in costs.